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A controlled comparison by the Tuberculosis Chemotherapy Centre, Madras, of the
merits of home as compared with sanatorium treatment for pulmonary tuberculosis showed
that, at the end of a year of chemotherapy with isoniazid plus p-aminosalicylic acid (PAS),
the response of the home patients closely approached that of the sanatorium patients. The
present report reviews the progress of those patients in the controlled comparison whose
disease had attained bacteriological quiescence by the end of the year of combined chemo-
therapy. During the second year, half of the patients received further chemotherapy, with
isoniazid alone, and half received a placebo, calcium gluconate. D ring he third year, half
of those who were treated with isoniazid in the second year and whose disease remained
quiescent continued to receive that drug and all the remaining patients with quiescent
disease received the placebo. In the second and third years all the patients were treated
at home and administered the medicaments to themselves.
It has been concluded from this follow-up study that in the second and third years
there was relatively little difference between the progress of the patients whose disease
attained quiescence following a year of domiciliary treatment with isoniazid plus PAS and
that of those whose disease attained quiescence following a year’s treatment with the same
drugs in sanatorium ; that a second or third year of furthe treatment with isoniazid alone
gave no better r sults than a year of combined chemotherapy, followed by careful observa-
tion of the patient and further chemotherapy if relapse occurred: and that the relapse rate
among the patients with residual cavitation at the end of the year of combined chemotherapy
was slightly higher than that among the patients with no residual cavitation at the end of
the first year.
An earlier report from the Tuberculosis Chemo-
therapy Centre, Madras, gave the findings of a
controlled comparison of home and sanatorium
treatment of pulmonary tuberculosis for a year, all
patients receiving isoniazid plus p-aminosalicylic
acid (PAS) (Tuberculosis Chemotherapy Centre,
1959). It was found that the response of the domi-
ciliary patients closely approached the results in the
patients treated in sanatorium. At the end of the
first year the patients with bacteriologically quies-
* From the Tuberculosis Chemotherapy Centre, Madras,
India.
c nt disease were allocated, at random, to treatment
with isoniazid alone for the second year, or to a
placebo. In a subsequent report (Velu et al., 1960b)
it was concluded, first, that “ in the second year
there was very little difference between the patients
whose disease attained bacteriological quiescence
following a year of domiciliary treatment and those
whose disease attained quiescence following a year’s
treatm nt with the same combination of drugs in
sanatorium. Secondly, there was no evidence that a
second year of treatment with isoniazid alone con-
ferred any benefit. Thirdly, the patients with residual
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DIAGRAMMATIC REPRESENTATION OF THE NUMBERS OF PATIENTS IN THE STUDY,
THEIR DISEASE STATUS AND TREATMENT
First-year study
(main comparison) lsoniazid plus PAS163 . . . . . . . . . . .._....................................... Home 82, Sanatorium 81
Second-year study
cavitation at one year fared slightly less well in the
second year than the patients without obvious
residual cavitation; isoniazid therapy for the second
year did not, however, reduce the likelihood of
relapse.” These same patients have now completed
three years and the present report describes their
progress in the second and third years. The numbers
of patients in the various categories and their treat-
ment in the second and third years are shown in the
accompanying chart. The present report includes
(a) a comparison of the patients whose chemo-
therapy was stopped at the end of one year with
those who received chemotherapy, with isoniazid
alone, for a second and in some cases for a third
year, (b) a comparison of the progress of the patients
in the home and sanatorium series, (c) th  influence
f residual cavitation at one year, the so-called
“ op n negative ”syndrome, on the progress in the
s cond and third years and (d) a comparison of the
patients whose chemotherapy was stopped at the end
of two years with those who received isoniazid alone
for a third year.In addition, the progress in the
second and third years is reported for the patients
whose bacteriological status at one year was in doubt
because an isolated positive culture had been
bt ined late in the course of the first year (see chart).
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The organization of the Centre, which is underCouncil of Great Britain, has been described in
the joint auspices of the Indian Council of Medicaldetail in ,an earlier report (Tuberculosis Chemo-
Research, the Madras State Government, the Worldtherapy Centre, 1959).
Health Organization and the Medical Research
I. GENERAL PLAN AND CONDUCT OF THE STUDY
Contrary to expert opinion, both in India and in
Europe, it proved possible to keep the co-operation
of the patients during their year of combined chemo-
therapy in the home and sanatorium comparison.
As a consequence it was decided that the patients
   whose disease was bacteriologically quiescent (as
defined on page 152) at the end of the year, whether
treated at home or in sanatorium, should be alloc-
ated at random to treatment for a second year with
daily isoniazid or with a daily placebo, calcium
gluconate (see chart). The patients continued to be
co-operative in the second year, and it was therefore
decided to make a comparison of two years and three
years of chemotherapy; the patients who had been
allocated to isoniazid in the second year and who
still had quiescent disease at the end of two years
were therefore allocated again at random to treat-
ment for a third year with daily isoniazid or with
daily calcium gluconate. (The patients who had been
allocated the placebo in the second year received
it in the third year also, unless their disease was no
longer quiescent at the end of two years.) All the
patients were to be treated at home in the second
and third years. The plan of the study, therefore,
evolved with experience of the co-operation which
could be obtained from the patients.
SOURCE OF CASES
The patients were drawn from the poorest sections
of the population of Madras City.All had presented
themselves at local chest clinics because of symptoms.
Mass radiography was not used as a source of
cases.
NUMBERS OF PATIENTS IN THE STUDY
A total of 130 patients in the main analysis of the
first report (Tuberculosis Chemotherapy Centre,
1959) were classified as having bacteriologically
quiescent disease at the end of the first year (see
chart above). Of these, 126 patients (57 home,
69 sanatorium) were allocated at random to calcium
gluconate (61 patients) or to isoniazid (65 patients)
for the second year, 42 having definite residual
cavi ation and 84 showing no evidence of residual
cavitation.These 126 patients may be divided
according to these criteria into eight subgroups
(T ble 1.) The remaining four patients (three home,
one s natorium), although kept under observation,
wer  not included in the random allocation for
r asons reported by Velu et al. (1960b).
In the second year five patients in the calcium
series and three in the isoniazid series relapsed
bacteriologically and one (isoniazid) died. At two
years, therefore, 56 patients who had received
calcium gluconate and 61 who had received isoniazid
still had quiescent disease. The former continued
on calcium gluconate, and 60 of the latter were
allocated at random to calcium gluconate (30 pa-
ients) or to isoniazid (30 patients) for the third year.
Of the 60 patients 27 had been treated at home in the
first year and 33 in sanatorium, 19 having had
TABLE 1
NUMBERS OF PATIENTS IN THE EIGHT SUBGROUPS











Total . . . 126
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residual cavitation at one year and 41 no residualTREATMENT IN THE SECOND AND THIRD YEARS
cavitation. One patient was not included in the
random allocation for the third year because heAll the patients were treated at home in the second
was going to Bombay and it was uncertain whetherand third years. The dosages of the two regimens
he would continue to co-operate in treatment. Hewere:
was prescribed calcium gluconate. Isoniazid :
A further 10 patients (seven home, three sanato-
rium), whose disease at one year was of doubtful200 mg daily, for patients weighing 100 lb. or more;
bacteriological status (Tuberculosis Chemotherapy175 mg daily, for patients weighing 80-99 lb;
Centre, 1959), are the subject of a subsidiary analysis150 mg daily, for patients weighing less than 80 lb.
in this report (see page 170). The daily dose was taken as one pill in the morn-
ing. If a patient increased in weight and moved into
CHEMOTHERAPY DURING THE FIRST YEAR
All the patients studied in the present report had
received isoniazid plus PAS (sodium salt) in two
doses daily for the first 12 months, those weighing
100 lb. or more having been prescribed 200 mg and
10 g daily, respectively, those weighing 80-99 lb.,
175 mg and 8.75 g, and those weighing less than
80 lb., 150 mg and 7.5 g daily.
ASSESSMENT OF CAVITATION AT ONE YEAR
The division of the patients into those with definite
residual cavitation at one year and those without
evidence of residual cavitation was made by an
independent assessor (one of the present authors-
J. H. A.– in the first week that he joined the Centre’s
staff) on the basis of the postero-anterior radiographs
and a tomographic series at one year (Velu et al.,
1960b).
DEFINITION OF BACTERIOLOGICAL QUIESCENCE
AT ONE YEAR
A patient’s disease was classified as bacterio-
logically quiescent at the end of the first year if
all the cultures for at least the last three monthly
examinations, after 10, 11 and 12 months of chemo-
therapy, had been negative. The patients had been
intensively investigated and had usually had from
seven to nine negative cultures at 10, 11 and
12 months.
a higher weight category, the dosage of isoniazid was
increased at the next monthly examination; if, how-
ever, the patient lost weight and moved into a lower
weight category, the dosage was not decreased.
Calcium :
500 mg of calcium gluconate a day, taken as one
pill in the morning.
ALLOCATION OF TREATMENT
Each patient who completed the first year of treat-
ment, whether at home or in sanatorium, and had
quiescent disease on the evidence of the then available
bacteriological data (the culture results of the elev-
enth and twelfth months were not usually available
at that time), was allocated to treatment for the
second year within a week of the completion of the
first year’s chemotherapy. The allocation of calcium
gluconate or isoniazid was made from two pre-
arranged lists, one for the patients with residual
cavitation and the other for patients without residual
cavitation. These lists were based on random sam-
pling numbers and had been incorporated in two  
series of numbered, sealed envelopes. The alloca-  
tion was made by the Centre’s statistical staff from   
the next envelope in the appropriate series. The
medical and statistical staff had no prior knowledge
of the treatment which any individual patient would
receive.
Each patient who completed the second year of
treatment with isoniazid and had quiescent disease
(on the evidence of the then available bacteriological
data) was allocated at random to treatment with
calcium gluconate or isoniazid for the third year
within a week of the completion of the second year’s
DEFINITION OF BACTERIOLOGICAL QUIESCENCE
AT TWO YEARS
A patient’s disease was classified as bacteriologi-therapy. The allocation was again made by the
tally quiescent at the end of the second year if allCentre’s statistical staff from two series of sealed
the cultures for at least the last six monthly examina-envelopes, one for patients with residual cavitation
tions had been negative. The patients had usuallyand the other for patients without residual cavitation
had eight negative cultures during this period.at the end of one year.
The patients had originally been admitted to treat-
ment in the period 24 September 1956 to 24 Sep-
tember 1957.
During the second year the patients attended the
Centre monthly for a month’s supply of their medi-
cine and for a routine examination. Their homes
were usually visited twice a month by a health
visitor, one visit being made to deliver a bottle for a
sputum specimen and the other, a surprise visit,
being made to count the stock of pills and, for the
patients receiving isoniazid, to collect a specimen of
urine, in order to check, by the naphthoquinone-
mercuric chloride test (Short & Case, 1957;
Gangadharam et al., 1958) that the drug was being
taken.
GENERAL MANAGEMENT
In the third year the patients attended the Centre
every month for a month’s supply of their medicine
and had a routine examination every three months.
A surprise visit to the home was usually made once
a month to count the stock of pills and, if the patient
was receiving isoniazid, to collect a specimen of urine
to test for the drug. Once every three months an
extra visit was paid to deliver a sputum bottle to the
home.
The patients were encouraged to undertake their
normal occupations and were often not at home
when visits were made.
laryngeal swabs from each patient were examined.
At 27, 30 and 33 months, the patients brought an
overnight sputum specimen, and a pair of laryngeal
swabs was also taken in the Centre.At h  end of the
third year, two overnight sputum specimens and a
pair of laryngeal swabs were examined. The stand-
ard procedure was therefore to obtain 14 bacterio-
logical specimens from each patient during the
second year and nine during the third year. Occasion-
ally, extra specimens were examined, especially if a
positive result had recently been obtained. (If a
patient relapsed bacteriologically (see definition
below) extra specimens were usually ordered. If the
patient deteriorated radiographically also, the rou-
tine was to change treatment and to examine three
specimens each month thereafter.) The sputum
specimens were examined by smear and culture, the
laryngeal swabs by culture only. Tests of sensitivity
to isoniazid and to PAS were performed on one posi-
tive culture each month. The techniques have been
described in an earlier report (Tuberculosis Chemo-
therapy Centre, 1959). Because of the difficulty
experienced in interpreting the results of the PAS-
sensitivity tests (Tuberculosis Chemotherapy Centre,
1960; Selkon et al., 1960), no further reference is
made to these results in this report.
COLLAPSE THERAPY AND RESECTION
None of the patients considered in this report had
any form of collapse therapy or resection during the
three years.
CLINICAL INVESTIGATIONS
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month. If, on inspection, it appeared to be only
saliva, it was discarded and a pair of laryngeal swabs
was obtained instead. At the end of the second year,
two overnight sputum specimens and a pair of
DEFINITION OF BACTERIOLOGICAL RELAPSE
Examinations and assessments were undertaken
monthly in the second year and 3-monthly in the
third year and included (a) a postero-anterior radio-
graph, (b) measurement of the weight (lb.) and (c) an
assessment of the degree of physical activity and of
the working capacity. The erythrocyte sedimenta-
tion rate (ESR Westergren, one-hour reading) was
measured every three months. At the end of two
years a series of tomographs was taken.
Patients who yielded two or more positive cultures
in a period of six months have been considered to
have relapsed bacteriologically. In the second year
this meant two or more positive cultures in seven
consecutive monthly examinations. In the third
year, when examinations were performed every
three months, this meant two or more positive cul-
tures in three consecutive examinations-for ex-
ample, at 30, 33 and 36 months. (The definition of
bacteriological relapse in the second year is more
stringent than that used in the report of Velu et al.
(1960).)
INDEPENDENT ASSESSMENT OF THE RADIOGRAPHS
BACTERIOLOGICAL INVESTIGATIONS
All the radiographic series for the second year
were shown to an independent assessor (one of the
In the second year the patients were asked to bringpresent authors–J. H. A.–in the first week that
an overnight sputum specimen to the Centre eachh  joined the Centre’s staff) who was unaware of
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the treatment allocated to any patient in the first
or in the second year. Apart from the cavitation
assessments, for which tomographic series were also
used, all the assessments were made from postero-
anterior radiographs. The assessor classified ( )
the extent of residual disease at one year, on the
basis of the lung-zone involvement, using standard
definitions (Daniels et al., 1948), (b) the lesions at
one year, as unilateral or bilateral, (c) the cavitation
at one year, as extensive, moderate, slight or nil,
(d) the cavitation at two years, as more, unchanged,
less or disappeared, in relation to the cavitation at
the end of one year, and (e) the radiographic changes
in the second year as exceptional, considerable,
moderate, or slight improvement, as no change, or as
slight, moderate,or considerable deterioration,
viewing the postero-anterior radiographs at one and
at two years.
For the assessments in the third year all the radio-
graphic series were shown to another independent
assessor (Dr Raj Narain) who was unaware of the
treatment allocated to any patient in the first,
second or third year. This assessor classified ( ) the
extent of residual disease at two years, on the basis
of the lung-zone involvement, (b) the lesions at two
years, as unilateral or bilateral, (c) the radiographic
changes in the third year, viewing the postero-
anterior radiographs at two and at three years,
and (d) the cavitation at three years in relation to the
cavitation at the end of the second year, viewing
the postero-anterior radiographs at two and at
three years. He was also shown, when he so desired,
the radiographs which had been taken at monthly
intervals in the first and second years and at 3-
monthly intervals in the third year, as well as the
tomographic series at one and at two years.
PLAN OF THE REST OF THE REPORT
Sections II to VII deal with patients all of whom
had bacteriologically quiescent disease at one year.
Section II. Comparison of the progress of the
61 patients who received one year of chemotherapy
with that of the 65 patients who received two or
three years of chemotherapy.
Section III. Comparison of the progress of the
57 patients who were treated at home for the first
year with that of the 69 patients who were treated
in sanatorium for the first year.
Section IV. Comparison of the progress of the
42 patients with definite residual cavitation at one
year with that of the 84 patients without residual
cavitation at one year.
Section V. Comparison of the progress of the
30 patients who received two years of chemotherapy
with that of the 30 patients who received three years
of chemotherapy (all the patients had bacterio-
logically quiescent disease at two years).
Section VI. (a) Results in the eight subgroups in
the three comparisons in sections II, III and IV;
(b) results for all the 126 patients in the eight sub-
groups combined.
Section VII. (a) Results for the four patients not
allocated at random to treatment for the second
year; (b) disease status at three years of all the 130
patients-i.e., the 126 allocated at random and the
four ot allocated at random.
Section VIII. Regularity of self-administration of
th  medicaments.
Section IX. Progress in the second and third
ye rs of the 10 patients whose bacteriological status
at one year was in doubt (Tuberculosis Chemo-
therapy Centre, 1959).
II. COMPARISON OF ONE YEAR OF CHEMOTHERAPY WITH TWO OR THREE YEARS
OF CHEMOTHERAPY
This section compares the progress in the secondof the patients had serious disease on their admission
and third years of the 61 patients who received oneto the first year of treatment. Most of the 126
year of chemotherapy with that of the 65 patientsti nts whose disease attained bacteriological quies-
who received two or three years of chemotherapy.cence at one year, and who were then allocated at
The former are termed the calcium series, and ther om to calcium gluconate or isoniazid for the
latter the isoniazid series. second year, also had severe disease on admission
CLINICAL AND RADIOGRAPHIC CONDITION
AT THE START OF THE FIRST YEAR
to treatment. Thus, at the start of the first year,
77 % of the 126 patients had bilateral disease and
89% had cavitated lesions, the cavitation being
It was shown in an earlier report (Tuberculosismoderate or extensive in 70%. All the patients had
Chemotherapy Centre, 1959) that a large proportiontubercle bacilli in their sputum on admission. Con-
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sidering the results of a single overnight specimen,
87% of the patients had a positive result on direct
smear examination, 41% having a 3-plus (heavy)
positive result.
CLINICAL AND RADIOGRAPHIC FEATURES AT THE
END OF THE FIRST YEAR
Before considering the results, the clinical and
radiographic features at the end of the first year are
compared, since the random allocation to treatment
in the second year was made at that time.
Age and sex
The distributions of estimated age (not tabulated
here) were very similar, 34% of the 61 calcium
patients and 29% of the 65 isoniazid patients being
under the age of 25 years; 18 % of the calcium and
17% of the isoniazid series were aged 45 years or
more. As to the sex distribution, 57 % of the patients
in the calcium series and 65 % in the isoniazid series
were male.
Clinical and radiographic condition
The assessments of the clinical and radiographic
condition at the end of the first year are given for the
calcium and isoniazid series in Table 2, Part A.
There were rather fewer patients weighing 80-89 lb.
in the calcium series than in the isoniazid series-
namely, 11 % as compared with 26%; however,
there were rather more patients weighing 100-109 lb.
in the calcium than in the isoniazid series-namely,
31% as compared with 22%. Of the patients in the
calcium series, 38 (62%) had an ESR of 21 mm or
more compared with 27 (42 %) in the isoniazid series,
an unexpectedly large difference (P (0.05). The dis-
tributions of the number of lung zones involved in
disease and the proportions with bilateral disease
were very similar for the two series. There were
similar proportions of patients in the two series with
residual cavitation at the end of the first year, but
six (9 %) patients in the isoniazid series had extensive
residual cavitation, as compared with none in the
calcium series. In summary, the two series were
similar at the start of the second year except that
rather more patients in the calcium series had a high
ESR, and that the isoniazid series was possibly at a
disadvantage in respect of the extent of cavitation.
CLINICAL RESULTS IN THE SECOND AND
THIRD YEARS
Deaths
There was one death among the 126 patients. This
occurred in a 48-year-old male patient (isoniazid,
home, cavitated). An isolated positive culture was
obtained at 15 months, this being the first for 13
months. It failed to grow on subculture and was
followed by five negative cultures at 16 months. The
patient’s general condition was frail and he died
suddenly late in the seventeenth month, following
acute pain in his left side and severe dyspnoea. The
possibility that the patient died as a result of a
spontaneous pneumothorax cannot be excluded.
There was no clear-cut evidence of activity in the
lesion and the radiographic appearances at 16
months showed that slight improvement had
occurred in the preceding four months. Permission
for a post-mortem examination was not given.
Bact riological relapses
Nine patients had a bacteriological relapse (as
defined on page 153), three (two calcium, one isonia-
zid) without a radiographic deterioration and six
(four calcium, two isoniazid) with a radiographic
deterioration, confirmed by an independent assessor
(Dr K. S. Sanjivi), necessitating a change of treat-
ment (Table 7, Part A). One of the latter (isoniazid)
als  had an haemoptysis.
Considering, first, the three patients who relapsed
bacteriologically without a radiographic deteriora-
tion, one (calcium, home, non-cavitated), a female
aged 22 years, yielded a single colony at 16 months
and another single colony at 21 months. At 24
months a positive culture with 1-plus growth (20-
100 colonies) was obtained. Further positive cul-
tures, each of two colonies, were isolated at 28 and
30 months, respectively. Sensitivity test results were
available for four of these five cultures; all were
sensitive to isoniazid. The five cultures thereafter
to the nd of the third year were negative although
the patient continued to receive calcium gluconate,
The second patient (calcium, home, non-cavitated).
a male aged 23 years, yielded two positive cultures
of 10 and 15 colonies, respectively, in the twenty-
seventh month, the strain tested being highly
resistant to isoniazid. All 15 cultures, 10 of sputum
and five of laryngeal swabs, from then until the end
of the third year were negative even though the
patient continued to receive calcium gluconate. A
smear-positive, culture-negative result was obtained
at 31 months, and another at 32 months. The third
patient (isoniazid, sanatorium, cavitated), a male
aged 53 years, produced nine positive cultures at
eight monthly examinations in the second year, the
umber of colonies being between one and seven in
eight of the cultures and l-plus growth in the ninth;
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TABLE 2
CONDITION OF PATIENTS AT THE END OF THE FIRST YEAR
Part A Part B Part C
Cavitation status
at the end of the first year
cavitated non-cavitated
42 84
No. % No. %
0 0 2 2
5 12 5 6
7 17 17 20
12 29 19 23
9 21 24 29




during the first year
home sanatorium
57 69




No. %  No. %
1 2 1 2
6 10 4 6
7 11 17 26
15 25 16 25
19 31 14 22
13 21 13 20
12 20 21 32







2 4 0 0
8 14 2 3
15 26 9 13
17 30 14 20
9 16 24 35
6 11 20 29110 or more
7 12 26 38
14 25 14 20
27 47 22 32
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8 13 12 18
21 34 20 31
18 30 17 26
9 15 12 18
2 3 3 5
0 0 0 0
1 2 3 4
7 12 13 19
18 32 23 33
18 32 17 25
11 19 10 14
2 4 3 4













3 5 1 2 1 2 3 4
14 23 18 28 12 21 20 29
44 72 46 71 44 77 46 67
42 69 42 65 36 63 48 70
10 16 10 15 9 16 11 16
9 15 7 11 9 16 7 10












a 1 lb = 0 . 4 5  k g.
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all eight strains tested were highly resistant to
isoniazid. Despite the fact that he had no radio-
graphic deterioration, chemotherapy was changed
in the twenty-sixth month and all the 20 cultures
from then to the end of the third year were nega-
tive.
Considering, next, the four calcium patients who
had a bacteriological relapse with a radiographic
deterioration, treatment was changed in the second
year for three and in the third year for one. Of these
patients, one (sanatorium, non-cavitated), a male
aged 18 years, had positive sputum findings at 14,
15, 16 and 17 months; the organisms were sensitive
to isoniazid. His treatment was changed in the
seventeenth month, when there was a radiographic
deterioration. Following the start of a new chemo-
therapeutic combination this patient yielded only
negative cultures from 26 months onwards, and
23 consecutive negative cultures had been obtained
by the end of the third year. The second patient
(also sanatorium, non-cavitated), a male aged
35 years, had a positive sputum specimen at 17
months, and treatment was changed at the end of
22 months, when a radiographic deterioration was
confirmed; the organisms remained sensitive to
isoniazid. The patient’s subsequent treatment was
complicated by an amoebic lung abscess, but during
treatment with a new combination of drugs all the
cultures from 32 months onwards were negative,
14 consecutive cultures having been examined by
the end of the third year. The third patient (home,
cavitated), a female aged 25 years, remained bacterio-
logically negative until 22 months, when a relapse
occurred with organisms sensitive to isoniazid. The
lesion showed radiographic deterioration and treat-
ment was changed at 24 months. From 25 months
onwards all the cultures were negative; 34 con-
secutive negative cultures had been obtained by the
end of the third year. Another female patient
(sanatorium, non-cavitated), aged 20 years, yielded
positive cultures at 14, 15 and 16 months, the two
strains tested being isoniazid-resistant. Nine con-
secutive negative cultures were then obtained up to
24 months, but at 25 months the patient produced
four colonies on culture, sensitive to isoniazid. Six
more consecutive negative cultures were obtained
but at 28 months she had a bacteriological relapse
(six positive cultures were obtained in a period of
12 days); one of these strains was tested and found
resistant to isoniazid. There was also a radiographic
deterioration and treatment was changed. All the
cultures from 31 months onwards were negative,
16 having been examined by the end of the third
ye r.
Considering the two isoniazid patients whose
chemotherapy was changed, one (sanatorium, cavit-
ated), a female aged 25 years, developed a positive
sputum at 15 months, the organisms being resistant
to isoniazid. She had a radiographic deterioration
and an haemoptysis and her chemotherapy was
changed in the seventeenth month. All the 50 con-
secutive cultures obtained from 18 months to the
end of three years were negative. The second patient
(sanatorium, cavitated), a female aged 20 years,
developed a positive sputum at 18 months with
organisms sensitive to isoniazid. She moved more
than seven miles away from the Centre and refused
to co-operate in a change of treatment until the
twenty-fourth month, when, being eight months
pregnant, she agreed to be admitted to sanatorium;
she discharged herself, however, soon after delivery
and discontinued her chemotherapy. In the thirty-
second month she reattended the Centre with very
far advanced disease, but was still uncooperative.
She eventually agreed to readmission to sanatorium
in the thirty-fourth month. At 36 months she was
bacteriologically positive and had advanced bilateral
disease.
It is not within the scope of this report to detail the
subsequent chemotherapy for patients who relapsed.
The standard procedure was to prescribe strepto-
mycin plus pyrazinamide (Velu et al., 1960a, 1961).
Isoniazid-sensitivity test results in the patients with a
bacteriological relapse
Of the six patients who had a bacteriological
relapse in the calcium series, four did so with iso-
niazid-sensitive organisms and two with highly iso-
niazid-resistant organisms (growth on 50 µg/ml).
Of the three patients with a bacteriological relapse
in the isoniazid series, one-namely, the uncooper-
ative patient described above-relapsed with iso-
niazid-sensitive organisms (there was evidence from
urine tests that she had been irregular in taking her
isoniazid) and two with resistant organisms (growth
on 1 µg/ml and on 50 µg/ml, respectively).
Patients who yielded isolated positive cultures
Five patients (two calcium, three isoniazid) yielded
isolated positive cultures (Table 7, Part A). Con-
sidering the calcium patients first, one (home, non-
cavitate ) yielded an isolated positive culture at 16
mont s and the other (sanatorium, non-cavitated)
at 24 months. Of the three patients in the isoniazid
series who yielded an isolated positive culture, one
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(home, non-cavitated) had an isolated positive cul-
ture at 13 months. The other two patients (both
sanatorium, non-cavitated) yielded an isolated posi-
tive culture at 14 and at 36 months, respectively. In
addition, one patient (isoniazid, home, cavitated)
yielded a positive culture in the fifteenth month
and died in the seventeenth month. A sensitivity
test was not available for this patient. Four of
the other five isolated positive cultures were sensitive
to isoniazid: the culture obtained at 24 months from
a calcium patient was resistant to isoniazid (growth
on 1 µg/ml).
Changes in the ESR
At one year nine (16%) of 56 patients in the cal-
cium series with observations available had had a
normal ESR (10 mm or less) as compared with 19
(32%) of 59 isoniazid patients (Table 3). At three
years the numbers had increased to 11 (20%) and
21 (36%), respectively. It will be observed that many
patients in both series retained high ESRs, the
numbers with ESRs of 51 or more being seven and
nine, respectively, at one year and eight and six,
respectively, at three years. Indeed, at three years
23 (41%) of the calcium and 27 (46%) of the iso-
niazid series still had ESRs of 21 or more.
Radiographic progress
The considerable majority of patients-namely,
49 (82%) of 60 in the calcium series and 52 (80 %) of
65 in the isoniazid series-showed no radiographic
change in the second year, only five of the calcium
and eight of the isoniazid patients showing some
radiographic improvement (Table 4). In the third
year 51 (89%) of 57 calcium and 54 (87%) of 62
isoniazid patients showed no change, while two and
five patients, respectively, showed slight improve-
ment. Since so few changes occurred in either year,
no separate assessment for the whole 2-year period
was undertaken.
Changes in cavitation status
Considering the patients with residual cavitation
at the end of the first year (Table 5), cavitation had
disappeared by the end of the second year in four of
19 patients in the calcium series as compared with
four of 23 in the isoniazid series and was less in five
and nine patients, respectively. Of a total of 16
patients with residual cavitation at two years in the
calcium series, cavitation had disappeared in one by
the end of the third year and was less in two, as corn-
pared with one and three, respectively, of 16 patients
in the isoniazid series.
8
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TABLE 4
CHANGES IN RADIOGRAPHIC APPEARANCES DURING THE SECOND AND THE THIRD YEAR
a Excluding throughout one patient (calcium, home, non-cavitated) who had cancer of the lung.
b On account of a bacteriological relapse with or without a radiographic deterioration.
Of 41 patients in the calcium series without cavita-
tion at one year, two showed cavitation at two years
as compared with none of 42 in the isoniazid series.
At two years, 41 patients in the calcium series had no
cavitation; one of these showed cavitation at three
years as compared with none of 46 in the isoniazid
series.
Number of culture results
Table 6, Part A, sets out the number of culture
results during the second and third years. The majo-
rity of patients in both series-namely, 71% of the
calcium and 70% of the isoniazid series–had 11 to
14 culture results in the second year, the average
number of results being 13.3 for each series (the
planned total was 14).
In the third year the intensity of investigation was
less and the majority of patients–namely, 64% of
the calcium and 66% of the isoniazid series–had
seven to nine culture results, the average number of
results for the former series being 8.9 and for the
latter 8.4 (the planned total was nine).
Disease status
Of the calcium series 53 (87%) patients and of the
isoniazid series 58 (89 %) yielded only negative cul-
tures in the second and third years (Table 7, Part A);
two (3 %) of the former series and three (5 %) of the
latter yielded an isolated positive culture. If these
isolated positive findings are regarded as unimpor-
tant, the proportion of patients with bacteriologi-
cally quiescent disease throughout the period was
90 % f r the calcium and 94 % for the isoniazid series.
Bacteriological relapse occurred in six (10 %) of
the calcium and three (5 %) of the isoniazid series in
the second and third years, four of the former and
two of the latter being associated with a radiogra-
phic deterioration, so that a change of treatment was
necessary (one of these patients had an haemoptysis
also). One isoniazid patient who showed no radio-
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a Assessments on standard radiographs and tomographic series for the second year and on standard radiographs for the
third year.
b On account of a bacteriological relapse with or without a radiographic deterioration.
c Excluding one patient who developed cancer of the lung.
TABLE 6. NUMBER OF CULTURE RESULTS DURING THE SECOND AND THE THIRD YEAR
Part DPart B Part C
Cavitation status at the
end of the first year
cavitated non-cavitated





No. % No. %
3 5 6 10
40 71 43 70
13 23 12 20
56 99 61 100
13.3 13.3
4 7 6 10
35 64 40 66
16 29 15 25
Place of treatment
during the first year
home sanatorium
No. % No. %
6 11 3  5
34 63 49 78
14 26 11 17







9 7.710 or less
11-14
15-18
83 7 0 .9
25
1 1 7   1 0 0 . 0           Total patients
Average number
of culture results 13.313.1 13.5






4 8 6 10
37 70 38 6 0
12 23 19 3 0
Third
Total patients b 116 100.0
Average number
of culture results 8.7
a Excluding throughout eight patients (five calcium, three isoniazid; two home, six sanatorium; four cavitated, four non-cavitated)
who relapsed bacteriologically in the second year and one patient (isoniazid, home, cavitated) who died.
b Excluding one patient (calcium, home, non-cavitated) who relapsed bacteriologically in the third year.
Second and third
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TABLE 7
DISEASE STATUS IN THE SECOND AND THIRD YEARS
Part DPart A Part B
Cavitation status at the








Q u i e s c e n t  d i s e a s e
All cultures negative
Isolated positive culture
R e l a p s e d  d i s e a s e
Bacteriological relapse (two or
more positive cultures) without
radiographic deterioration
Bacteriological relapse with ra-
diographic deterioration neces-
sitating a change of treatment
D e a t h
Q u i e s c e n t  d i s e a s e
All cultures negative
Isolated positive culture
R e l a p s e d  d i s e a s e
Bacteriological relapse (two or
more positive cultures) without
radiographic deterioration
Bacteriological relapse with ra-
diographic deterioration neces-
sitating a change of treatment
a This patient had a bacteriological relapse in the second year and treatment was changed in the third year because the patient
remained persistently bacteriologically positive.
b This patient produced an isolated positive culture in the fifteenth month and died in the seventeenth month (see text, page155).
c Including one patient who continued on calcium and yielded only negative cultures from the seventeenth month up to the
end of the second year (see text, page 157).
graphic deterioration had chemotherapy changed
because positive cultures were obtained persist-
ently.
The lower half of Table 7 gives the corresponding
findings for the second year only. It will be seen that
there was very little difference between the findings
in the second year and those in the second and third
years combined. In fact, the only changes in the
third year were that one isoniazid patient yielded an
isolated positive culture; one calcium patient, who
had had a bacteriological relapse in the second year,
had a radiographic deterioration necessitating a
change of treatment in the third year; and another
patient in the calcium series had a bacteriological
relapse. In summary, the great majority of patients
in both series retained quiescent disease throughout
the period and all except one of the relapses occurred
in the second year
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III. COMPARISON OF THE HOME AND SANATORIUM SERIES
This section compares the 57 home and 69 sana-
torium patients with bacteriologically quiescent
disease at one year who were allocated at random to
treatment in the second year.
CLINICAL AND RADIOGRAPHIC CONDITION AT THE END
OF THE FIRST YEAR
A comparison of the clinical and radiographic
features at the end of the first year is given for the
home and sanatorium patients in Table 2, Part B.
It will be seen that the home patients, who had had
an inferior diet (Tuberculosis Chemotherapy Centre,
1959; Ramakrishnan et al., 1961b) weighed less than
the sanatorium patients; 15 (26%) of the former as
compared with 44 (64%) of the latter weighed
100 lb. or more. In addition, 38 % of the sanatorium
patients had normal ESRs (10 mm or less) as com-
pared with 12 % in the home series. Considering the
radiographic features, 54 % of the home patients and
43 % of the sanatorium patients had residual lesions
in three or more lung zones; 77 % of the home and
67% of the sanatorium patients had bilateral
disease; and 37 % of the home and 30 % of the sana-
torium series had residual cavitation. In summary,
at the end of the first year the home patients
weighed less and had higher ESRs and rather more
extensive residual radiographic lesions than the
sanatorium patients.
CLINICAL RESULTS IN THE SECOND AND
THIRD YEARS
Deaths
The one death among the 126 patients occurred
in a male in the home series. His case is summarized
on page 155.
Changes in the ESR
At one year 13 % of 55 home and 35 % of 60 sana-
torium patients had normal ESRs (Table 3). At
three years the corresponding proportions were 25 %
and 30 %, respectively; 47 % of the home and 40 %
of the sanatorium patients still had ESRs of 21 mm
or more.
Radiographic progress
The majority of patients in both series-namely,
46 (82%) of the home and 55 (80%) of the sana-
torium series-showed no change in the radiographic
appearances in the second year (Table 4), and five
home nd eight sanatorium patients improved radio-
graphically. In the third year 48 (89 %) of the home
 57 (88%) of the sanatorium patients showed no
change and three patients in the home and four in the
sanatorium series improved radiographically.
Changes in cavitation status
Considering the patients with residual cavitation
at the end of the first year (Table 5), cavitation
disappeared in four of 21 home patients as compared
with four of the same number of sanatorium patients
in the second year and was less in 10 and four
patients, respectively. In the third year it disap-   
peared in two of 16 home and none of 16 sanatorium
patients, and was less in two and three patients,
respectively.
Of 35 home patients who had no residual cavita-
tion at one year, one showed cavitation at two years
as did one of 48 patients in the sanatorium series.
Of 38 home patients without cavitation at two years,
none showed cavitation at the end of the third year
as compared with one of 49 patients in the sana-
torium series.
Number of culture results
Table 6 sets out the number of culture results
during the second and third years. The majority of
patients in both series-namely, 63% of the home
and 78 % of the sanatorium series–had 11 to 14
culture results in the second year, the average number
of results being 13.1 for the home series and 13.5 for
the sanatorium series. In the third year the intensity
of bacteriological investigation was less and the   
majority of patients-namely, 70% of the home and
60% of the sanatorium series-had seven to nine    
culture results, the average number of cultures for the
former series being 8.6 and for the latter 8.7.
Disease status
Considering both the second and third years
together (Table 7, Part B), 51(89 %) of the home and
60 (87%) of the sanatorium patients yielded only
negative cultures. Two (4%) of the home and three
(4%) of the sanatorium patients yielded an isolated
positive culture. The proportion of patients with
bacteriologically quiescent disease was 93 % for the
home and 91% for the sanatorium series.
B cteriological relapse occurred in three (5%) of
the home and six (9%) of the sanatorium patients,
o e of the home and five of the sanatorium patients
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having a radiographic deterioration also, necessi-half of Table 7). The only changes that occurred in
tating a change of treatment. The sixth sanatoriumthe third year were that one sanatorium patient
patient had treatment changed because of persistentyielded an isolated positive culture, one home patient
positive cultures. (Details of the individual patientshad a bacteriological relapse without a radiographic
who relapsed bacteriologically have already beendeterioration and another sanatorium patient, who
given (see page 155 et seq.).) The position showedhad already had a bacteriological relapse in the
very little change from that in the second year (lowersec nd year, had a radiographic deterioration.
IV. COMPARISON OF THE CAVITATED AND NON-CAVITATED SERIES
In this section the progress in the second and third
years of the 42 patients with residual cavitation at the
    end of the first year is compared with that of the
84 patients who had no definite evidence of residual
cavitation. Before considering the progress in the
second and third years, the clinical and other
radiographic features at the end of the first year are
compared to see whether the cavitated and non-
cavitated series differed in other respects also.
AGE AND SEX
There was a major difference in the distribution of
estimated age for the two series; 14% of the 42
patients in the cavitated series were under 25 years
of age, as compared with 40% of the 84 in the non-
cavitated series. At the other extreme, 29% of the
patients in the cavitated series were aged 45 years or
more, as compared with 12% of the non-cavitated
series. The sex distribution was similar in the two
series, 57% of the cavitated and 63 % of the non-
cavitated series being males.
CLINICAL AND RADIOGRAPHIC CONDITION AT THE END
OF THE FIRST YEAR 
The assessments of the clinical and radiographic
condition at one year are given for the cavitated and
non-cavitated series in Table 2, Part C. The weight
distributions were similar. There was a striking dif-
ference between the two series in the distributions of
the ESRs, 7 % of the cavitated series having a normal
ESR (10 mm or less) as compared with 36% of the
non-cavitated series (P < 0.01). The cavitated series
had more extensive residual lesions, as indicated by
the number of lung zones involved in disease, for
only 7% had less than two lung zones involved as
compared with 25 % of the patients in the non-
cavitated series.Correspondingly, 86% of the
patients in the cavitated series as compared with
64 % in the non-cavitated series had bilateral disease.
I  summary, the cavitated series had higher ESRs
a d more extensive residual radiographic lesions
han the non-cavitated series.
CLINICAL RESULTS IN THE SECOND AND
THIRD YEARS
Deaths
The one death among the 126 patients occurred
in a male in the cavitated series. His case is sum-
marized on page 155.
Cha ges in the ESR
Two (6%) of 36 patients in the cavitated series
had had a normal ESR at one year compared with
26 (33 %) of 79 in the non-cavitated series. At three
years the corresponding proportions were 22% and
30 %, respectively.At three years 50 % of the cavit-
ated series and 41 % of the non-cavitated series still
had an ESR of 21 mm or more.
Radiographic progress
In the second year (Table 4) 30 (71%) of 42
patients with cavitated lesions showed no change
and six (14 %) showed radiographic improvement,
as compared with 71 (86 %) and seven (8 %), respec-
tively, of 83 patients assessed in the non-cavitated
series. In the third year, the majority of patients in
both series-namely, 28 (74%) of 38 patients in the
cavitated series and 77 (95%), of 81 in the non-
cavitated series-showed no change. Again the
numb rs who improved were small-namely, five
(13 %) of the cavitated series and two (2%) of the
non-cavitated series. In summary, a majority of
patients in both series showed no change in the
second year and no change in the third year.
Changes in cavitation status
Considering the 42 patients with residual cavita-
tion t one year (Table 5), cavitation had disappeared
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in eight and was less in 14 by the end of the second
year. There were 32 patients with residual cavitation
at the beginning of the third year; in two of these
patients cavitation had disappeared by the end of the
third year and in five of them it was less.
Of the 83 patients assessed as having no cavitation
at one year (Table 5), two showed cavitation at the
end of the second year. At the beginning of the
third year there were 87 patients assessed as having
no cavitation; cavitation was apparent in one of
these at the end of the third year.
In summary, there was little change in the 2-year
period in the patients with no cavitation, but in
the patients with cavitation there was more evidence
of improvement in the second than in the third
year.
Number of culture results
Table 6 sets out the number of culture results
during the second and third years. The majority
of patients in both series-namely, 68 % of the cavi-
tated and 72% of the non-cavitated series-had 11
to 14 culture results in the second year, the average
number of results being 13.2 for the cavitated series
and 13.4 for the non-cavitated series. In the third
year the intensity of investigation was less and the
majority of patients-namely, 70% of the cavitated
and 62% of the non-cavitated series-had seven to
nine culture results, the average number of cultures
being 8.8 and 8.6, respectively.
Disease status
Considering the second and third years together,
37 (88%) of the patients in the cavitated and 74
(88%) of those in the non-cavitated series yielded
only n gative cultures (Table 7, Part C). A further
five (6%) in the non-cavitated series yielded an
isolated positive culture so that the proportion of
patients with quiescent disease in the two series was
88 % for the cavitated and 94 % for the non-cavitated
series. Three (7%) patients in the cavitated series
relapsed bacteriologically with a radiographic deterio-
ration necessitating a change of treatment, as did   
three (4%) in the non-cavitated series. There was   
very little change in the third year. One patient
(non-cavitated) produced an isolated positive culture.
Another patient (non-cavitated) relapsed bacterio-
logically and a third patient, also in the non-cavitated
s ries, who had relapsed bacteriologically in the
second year, had treatment changed in the third
year ft r a radiographic deterioration. It may be
concluded that the great majority of patients in
both series retained quiescent disease throughout
the period and there was only a little evidence that
the cavitated series fared less well than the non-
cavitated series.
V. COMPARISON OF THE PATIENTS ALLOCATED AT RANDOM
TO CALCIUM OR TO ISONIAZID FOR THE THIRD YEAR
This section compares the progress in the third
year of the 60 patients who received one year of
isoniazid plus PAS, either at home or in sanatorium,
followed by one year of isoniazid at home, and who
were then allocated at random to a third year of
treatment at home, either with calcium gluconate,
the “ 2-year series ” (30 patients), or with isoniazid,
the “ 3-year series ” (30 patients). All the patients
had bacteriologically quiescent disease at the end of
the first and at the end of the second year. One
patient in the isoniazid series voluntarily stopped
his chemotherapy at 27 months. He was followed
up and had quiescent disease at three years. He
has been included in the analysis.
Before considering the results of treatment in the
third year, the clinical and radiographic condition
of the patients on admission to treatment, at the
end of the first year and at the end of the second
year are compared to see if the two series were  
similar.
CLINICAL AND RADIOGRAPHIC CONDITION
Most of the patients in both series were ill and
had extensive lesions when they were originally
admitted to treatment. Thus, at that time, 22 of the
30 pa ients in the 2-year series and 20 of the 30 in
the 3-year series had moderate or extensive cavita-
tion; 22 patients in each series had bilateral disease
and 21 in each series had four, five or six lung zones
involved. The ESR was 51 mm or more in 26
p tients in the 2-year series and 20 in the 3-year
series. Of the patients in the 2-year series, 15 were
or ginally treated at home as compared with 12
i  the 3-year series.
A the nd of the first year there was very little
difference between the two series. In the 2-year
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series 11 patients and in the 3-year series eight TABLE 8
patients had residual cavitation at one year. CONDITION AT THE END OF THE SECOND YEAR
The clinical and radiographic features at the end OF THE PATIENTS ALLOCATED AT RANDOM TO
of the second year, when the random allocation toCALCIUM IN THE THIRD YEAR (THE P-YEAR SERIES) OR
treatment for the third year was made, are given inTO ISONIAZID (THE 3-YEAR SERIES)
Table 8. It will be seen that there were no important
differences between the two series in respect of the
factors tabulated.
2-year series 3-year series
In summary, the differences between the two
series at the start of treatment, at the end of the
first year and at the end of the second year were
small. In the 2-year series there were more patients
who had received the first year’s treatment at home,
and more who had had residual cavitation, the
“ open-negative ”syndrome, at one year than there
were in the 3-year series.
CLINICAL RESULTS IN THE THIRD YEAR
Changes in radiographic appearances
Of the 30 patients in the 2-year series, three
showed slight radiographic improvement in the
third year, 26 showed no change and one showed
slight deterioration, as compared with two, 27 and
one, respectively, of the 30 patients in the 3-year
series.
Changes in cavitation
Eight patients in each series had residual cavitation
at two years. In the 2-year series it had disappeared
by the end of the third year in one patient, was less
in two, was unchanged in four and was more in one
patient. In the 3-year series, the cavitation was less
at the end of the third year in one patient, unchanged
in three and more in four. In each series 22 patients
had no cavitation at the end of the second year;
none of these had cavitation at the end of the
third year.
Number of culture results
The average number of culture results in the third
year was 8.5 for each series.
Culture and sensitivity test results
All the cultures examined in both series throughout
the third year were negative, except one, sensitive to
isoniazid, from a patient (sanatorium, cavitated) in
the 3-.year series.He produced an isolated positive
laryngeal swab culture at 36 months with a growth
of 16 colonies. Two overnight sputum specimens and
another pair of laryngeal swabs which were also
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Disease. status at three years patient in the 3-year series who yielded an isolated
All the patients in both series had bacteriologicallypositive culture was also presumed to have quiescent
quiescent disease throughout the third year. The disease.
VI. RESULTS IN THE EIGHT SUBGROUPS OF THE THREE MAIN
  COMPARISONS AND PROGRESS OF ALL THE 126 PATIENTS
WITH QUIESCENT DISEASE AT ONE YEAR
RESULTS IN THE EIGHT SUBGROUPS OF THE THREE
MAIN COMPARISONS
The 126 patients with bacteriologically quiescent
disease at one year who were allocated at random to
treatment with calcium gluconate or isoniazid in the
second year may be classified in eight subgroups.
The number of patients in each subgroup who had
bacteriologically quiescent disease throughout the
second and third years is given in Table 9. Although
the figures are small they do not suggest that there is
any important difference between the subgroups
contributing to the comparisons already presented.
PROGRESS OF ALL THE 126 PATIENTS WlTH QUIESCENT
DISEASE AT ONE YEAR
In view of the finding that there was comparatively
little difference in the response of the patients in the
eight subgroups, it is legitimate to amalgamate the
findings for all the patients.Thi  subsection therefore
studies the progress of all the 126 patients who had
bacteriologically quiescent disease at one year.
Radiographic progress
The great majority of the patients-namely, 81%
of those assessed in the second year and 88% of
those assessed in the third year–showed no radio-
graphic change (Table 4); 10 % and 6 %, respectively,
showed radiographic improvement.
Changes in cavitation
Considering the 42 patients with cavitation at
the end of the first year, cavitation had disappeared
by the end of the second year in eight and was less
in 14 (Table 5). Considering the 32 patients who
had residual cavitation at the end of the second
year, cavitation had disappeared by the end of the
third year in two and was less in five. Of the 83
patients with no residual cavitation at the end of
the first year, two showed cavitation at the end of the
second year. There were 87 patients who had no
cavitation at the end of the second year; of these,
one showed cavitation at the end of the third
year.
Number of culture results
In the second year 70.9 % of the patients had 11 to
14 culture results, the average number of results
being 13.3 (Table 6, Part D). In the third year the
majority of patients-namely, 64.7%–had seven to
nine culture results; the average number was 8.7.
Disease tatus
In the second and third years, five (4.0%) of the
126 patients yielded an isolated positive culture
(Table 7, Part D).Three (2.4 %) had a bacteriological
relapse without a radiographic deterioration and six
(4.8%) more patients had a bacteriological relapse
TABLE 9
NUMBER OF PATIENTS IN THE EIGHT SUBGROUPS WITH
BACTERIOLOGICALLY QUIESCENT DISEASE
THROUGHOUT THE SECOND AND THIRD YEARS
Place of Cavitation
treatment status at the
during the end of the
first year first year
Home
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with a radiographic deterioration necessitating a
change of treatment. In all, therefore, nine (7.1%) of
the patients had had a bacteriological relapse. The
corresponding figure for the second year was eight
(6.3 %) ; in other words, all except one of the bacterio-
logical relapses occurred in the second year.
Prognostic factors
An analysis (not tabulated here) was undertaken
to investigate whether there were any factors of
prognostic importance in the nine patients whose
disease relapsed in the second or the third year.
There was only a slight suggestion that these patients
had more extensive lesions on their original admis-
sion to treatment than those whose disease continued
to remain quiescent. Thus, on admission, six (67%)
of the nine had five or six lung zones involved in
disease as compared with 43 (37%) of the 117 with
persisting quiescent disease. All nine had bilateral
disease as compared with 88 (75%) of the 117; six
(67%) of the former had a 3-plus (heavy) direct
smear on sputum examination as compared with 46
(39 ) of the latter. Initial cavitation was not a
factor of prognostic importance, neither was the
ESR nor the age.Four (44%) of the nine patients
whose disease relapsed were males, as compared
with 73 (62%) of those with persisting quiescent
disease.
There was little difference in the month of the
o iginal sputum conversion; seven (78 %) of the nine
who relapsed had converted their sputum to nega-
tivity within the first three months as compared with
77 (66%) of those with quiescent disease throughout
the s cond and third years.
Considering the condition of the patients at one
year, th re was no difference between those who
relapsed and those who did not in terms of the ESR,
but four (44%) of the former and 22 (19%) of the
latter ad four or more lung zones involved in
disease, all the former and 81 (69%) of the latter
having bilateral disease.Four (44%) of the nine
and 38 (32%) of the 117 had residual cavitation.
VII. RESULTS IN PATIENTS NOT ALLOCATED TO TREATMENT AT RANDOM
AND DISEASE STATUS AT THREE YEARS OF ALL PATIENTS WITH QUIESCENT
DISEASE AT ONE YEAR
RESULTS IN THE FOUR PATIENTS NOT ALLOCATED AT
RANDOM TO TREATMENT IN THE SECOND YEAR
Of the four eligible patients with quiescent disease
at one year who were not included in the random
allocation to treatment in the second year, one
patient (home, cavitated) died of a carcinoma of the
oesophagus in the fifteenth month. Two patients
(one home, one sanatorium; both non-cavitated), who
received the placebo in the second and third years, yiel-
ded only negative cultures. The fourth patient (home,
cavitated), who continued on isoniazid plus PAS, yiel-
ded positive cultures, resistant to isoniazid, at 15, 19,
23 and 24 months, had a radiographic deterioration
and had his treatment changed at 25 months.
  DISEASE STATUS AT THREE YEARS OF THE 130 PATIENTS
WITH QUIESCENT DISEASE AT ONE YEAR
The above four patients were included in an
analysis of the disease status at three years of all
the 130 patients with quiescent disease at one year.
Patients have been classified as bacteriologically
qui sc nt at three years if all their cultures were
negative in the last six months of the period,
irrespective of whether they had continued on the
prescribed treatment or had had their treatment
changed owing to a relapse. Of the 130 patients,
two had died, one of carcinoma of the oesophagus
and the other from a cause which could not be
established (see page 155); 126 patients had quiescent
disease and only two patients still had active disease.
Of these, one patient, who had persistently been
uncooperative and had interrupted her chemo-
therapy on two occasions, still had a positive
sputum and advanced disease; the other was under
treatment and, although having active disease by
the above stringent definition, had yielded only
neg tive cultures in the last five months of the
period.
VIII. REGULARITY OF SELF-ADMINISTRATION OF THE MEDICINE
Much emphasis was laid on the importance ofof the pill stocks at surprise visits to the home for
taking the medicaments regularly. The two methodsall the patients, and, only for the patients who
that were used to check the regularity were countsre eived isoniazid, tests for the presence of the drug
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TABLE 10
REGULARITY OF SELF-ADMINISTRATION OF MEDICINE DURING THE SECOND AND THE THIRD YEAR




Number of patients with one or more
pill counts a
Total number of occasions on which
pills were counted
Average number of pill counts per patient
Number of occasions on which incorrect
pill stocks were found
Percentage of occasions on which In-
correct pill stocks were found
Number of
pill counts b
patientswith one or more
Total number of occasions on which
pills were counted
Average number of pill counts per patient
Number of occasions on which incorrect
pill stocks were found
Percentage of occasions on which in-
correct pill stocks were found
Treatment
calcium isoniazid home sanatorium male
55 61 53 63 70
355 427 331 401 432
6.5 7.0 7.2 6.4 6.2
68 87 84 93
19.2 20.4 22.0 21.5




































a Excluding five patients (three calcium, two isoniazid; one home, four sanatorium; two male, three female) who had their treat-
ment changed on account of a bacteriological relapse with a radiographic deterioration and one patient (isoniazid, home, male)
who died.
b Excluding one patient (isoniazid, home, male) who discharged himself after having received the allocated treatment for three
months and two patients (one calcium, one isoniazid; both sanatorium; one cavitated, one non-cavitated) who had their treatment
changed on account of a bacteriological relapse with or without a radiographic deterioration.
in specimens of urine obtained at the routine visits
to the Centre and at surprise visits to the home. A
urine specimen was tested for isoniazid each time
a patient receiving this drug visited the Centre
(except in the case of females who were menstruat-
ing). The results of these routine tests permit valid
comparisons of the regularity of medicine-taking.
The results of the corresponding tests on specimens
obtained at surprise visits to the home, on the other
hand, may be subject to bias, since many patients,
especially the males, were not at home when visits
were made. Occasionally, also, a doctor would order
an extra surprise visit because a patient had recently
yielded a negative result. Pill counting is subject to the
same sources of bias, but was the only method avail-
able in this study for checking the regularity with
which the patients took the placebo,calcium gluconate.
PILL COUNTS
Table 10 sets out the findings for the counts of
the patients’ stocks of pills at surprise visits to the
homes for the second and third years separately.
The average number of counts in the second year
was 6.5 for the patients in the calcium series and
7.0 for those in the isoniazid series. Of a total of
355 counts in the calcium series, 19.2% disclosed    
incorrect stocks as compared with 20.4% of 427
counts in the isoniazid series. Comparing the pa-
tients treated at home in the first year with those
tr ated in sanatorium, inaccuracies in the stock of
ills were found in the second year in 22.0% of the
former and 17.7% of the latter. The male patients
had inaccurate stocks at 21.5 % of the counts and
th  f males at 17.7 %.
As a result of the random allocation procedure at
two years, the number of patients receiving calcium
gluconate in the third year whose pill stocks were
checked increased to 83, whereas the corresponding
number of those receiving isoniazid fell to 26. The
average number of pill counts per patient in the
third year was 8.2 for the calcium series and 8.1 for
the isoniazid series. Of a total of 684 counts in the
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TABLE 11
REGULARITY OF SELF-ADMINISTRATION OF tSONIAZID DURlNG THE SECOND AND THE THIRD YEAR
(AS ASSESSED BY THE NAPHTHOQUINONE-MERCURIC CHLORIDE TEST ON URINE SPECIMENS)
Second
Third
Number of patients with one or
more test results a
Total number of test results
Average number of test results
per patient
Number of test results which were
negative
Percentage of test results which
were negative
Number of patients with one or
more test results b
Total number of test results
Average number of test results
per patient
Number of test results which were
negative
Percentage of test results which
were negative
Specimens at planned visits to the Centre
place of treatment
during the first year
home sana-torium male female
place of treatment
during the first year
sex
home sana-torium male female
27 35 41 21 25 30 35 20
393 466 581 278 172 173 179 166
14.6 14.2 13.2 6.9 5.8 5.1 8.3






33.1 27.7 25.7 35.5
11 18 22 7 11 16 21 6







7.6 5.8 4.2 10.0




35.7 29.3 25.0 41.7
sex
Specimens at surprise visits to the home
a Excluding one patient (home, male) who died and two patients (both sanatorium, female) who had their treatment changed
on account of a bacteriological relapse with a radiographic deterioration.
b Excluding one patient (home, male) who discharged himself after having received the allocated treatment for three months.
calcium series, 25.1% revealed inaccurate stocks, as
compared with 21.0% of 210 counts in the isoniazid
series. The general order of the irregularities was
slightly higher in the third than in the second year.
   Comparing the patients treated at home in the first
    year with those treated in sanatorium, inaccuracies
in the stocks in the third year were found in 26.8 %
of the former and 21.5 % of the latter. The findings
for the males and females were 21.9 % and 27.0%,
respectively.
URINE TESTS
For the patients in the isoniazid series only, urine
specimens were obtained at all the routine visits to
the Centre and at surprise visits of the staff to the
home. The naphthoquinone-mercuric chloride test
(Short & Case, 1957) was performed on these
specimens and, if a negative result was obtained, a
hydrolysis test was carried out (Gangadharam et
al., 1958). Table 11 sets out the total number of
est  performed on urine specimens and the numbers
that gave negative results. The findings for the tests
performed on specimens obtained at routine visits
of the patients to the Centre and those on the
specimens obtained at surprise visits to the home are
presented separately for each year. Considering first
the specimens obtained at the routine visits to the
Centre, in the second year 23.2% of the results for
the patients initially treated at home were negative,
as compared with 20.8 % for the patients who were
initially treated in sanatorium.Considering the
male patients, 22.4% of the tests were negative, as
compared with 20.9% of the tests for the female
patie ts. For surprise specimens the corresponding
four pr portions were 33.1%, 27.7 %, 25.7 % and
35.5 %. Thus, the surprise visits revealed a some-
wha  greater degree of irregularity, and it is likely
that ome of the patients were more regular in taking
their isoniazid on the days of their visits to the
Centr  than on other days. It will be noted that the
female patients were more irregular than the males.
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The greater irregularity amongst the patients treated
at home was due to this fact, for further analysis
(not tabulated here) showed that the home males
yielded negative results in 25.3% of surprise tests
and the home females in 43.8%; the finding in the
sanatorium males was 26.2 % and in the sanatorium
females 29.0 %.
In the third year, the findings are based on smaller
numbers, but the proportions of tests with negative
results were 22.4% for the patients treated at home
in the first year and 18.9 % for those treated in sana-
torium, and 18.8 % for the males and 26.4 % for the
f male . The tests at surprise visits again yielded
evidence of greater irregularity, the corresponding
proportions being 35.7%, 29.3 %, 25.0% and 41.7%,
respectively. It may be concluded that the general
order of irregularity was the same for both the second
and he third year.
IX. PATIENTS WITH DISEASE OF DOUBTFUL BACTERIOLOGICAL STATUS
AT ONE YEAR
As reported earlier (Tuberculosis Chemotherapy
Centre, 1959), 10 patients (seven home, three sana-
torium) were classified as having disease of doubtful
bacteriological status at one year. These were
“ patients whose cultures were all negative at three
or more consecutive monthly examinations, but
who produced an isolated positive culture at one
of the last three monthly examinations–i.e., at 10,
11 or 12 months ”.These 10 patients represented
6.1% of the total of 163 patients in the main analysis.
Their progress during the second year has already
been reported (Velu et al., 1960b). This section
summarizes their progress during the second and
third years.
Of the seven home patients, one had erroneously
been regarded at the time as having had active
disease at one year (Velu et al., 1960b) and, for this
reason, continued on the originally prescribed
isoniazid plus PAS in the second and third years.
She produced another positive culture at 13 months,
but all the 12 cultures between then and the end of
the second year were negative and at two years her
disease was bacteriologically quiescent. At 27 months
the patient produced two positive cultures, which
were followed by a radiographic deterioration, and
her chemotherapy was changed at 30 months. The
remaining six home patients were allocated at
random to treatment with isoniazid or the placebo
in the second year. Of these, four (two calcium,
non-cavitated; one calcium, cavitated; one isoniazid,
cavitated) yielded only negative cultures in the second
and third years.One patient (calcium, non-cavitated)
yielded growth of a single colony at 33 months,
sensitive to isoniazid. The sixth home patient
(cavitated), who had isoniazid throughout the
second and third years, yielded positive cultures at 13,
15, 16 and 18 months. The sputum then became
n gative and nine consecutive negative cultures  
w re obtained. At 27 months she yielded a positive
culture with growth of six colonies and at 30 months
anoth r with growth of two colonies. She then
became bacteriologically negative again. At 36
months she yielded another positive culture with
1-plus growth. All the eight strains were resistant
to isoniazid.
Considering the three sanatorium patients, also
allocated at random to treatment with isoniazid or
the placebo for the second year, two (calcium, non-
cavitated) yielded only negative cultures throughout
the second and third years. The third, who had
yielded a positive culture at 12 months, also yielded
positive cultures at 13, 14, 15 and 16 months. He
had a radiographic deterioration and his treatment
was changed in the seventeenth month. (This
patient’s organisms alternated between being sen-
sitive to isoniazid and resistant at a low level (growth
on 0.2 µg/ml but not on 1 µg/ml, repeated at a
second test on the same strain).)
In summary, the three patients who had a bacterio-
logical relapse had all had positive cultures at 12 and
13 months, i.e., the positive culture at 12 months,
in the event, proved to be the commencement of
the relapse.
Th  disease status at three years was assessed for
ll 10 patients irrespective of whether or not the
chemotherapy had been changed owing to a relapse.
Eight had quiescent disease at three years, that is,
ha  yielded no positive cultures in the last six months
of e period. One patient was presumed to have
qu scent disease; he had yielded a single colony
a 33 months. The tenth patient, who had received
isoniazid in the second and third years, had active
dise se at the end of the period.
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X. DISCUSSION
The present report is mainly concerned with the
progress during the second and third years of all
the 130 patients whose pulmonary tuberculosis had
attained bacteriological quiescence at the end of a
year of the prescribed chemotherapy in a comparison
of home and sanatorium treatment in a total of
163 patients. The patients, most of whom had very
extensive lesions on admission to treatment, had
been drawn from the lower income groups or the
unemployed in Madras City, which is the largest
urban community in South India. The living con-
ditions were poor, the majority of the families being
overcrowded, and the dietary standards low (Tuber-
culosis Chemotherapy Centre, 1959; Ramakrishnan
et al., 1961b).
In the second year 126 of the patients were alloc-
ated at random to treatment either with isoniazid
alone (65 patients) or with a placebo, calcium
gluconate (61 patients). Of the former, 61 still had
quiescent disease at two years, and 60 of these were
allocated at random to treatment for a third year
either with isoniazid alone (30 patients) or with
calcium gluconate (30 patients). The patients who
had been allocated the placebo in the second year
continued on it for the third year, unless their
disease was no longer quiescent at the end of two
years. Of the 126 patients, eight (6.3%) had a
bacteriological relapse in the second year. One more
patient had a relapse in the third year, giving a
total of nine (7.1%) for the 2-year period. The
relapse rate compares favourably with the findings
of other workers. For example, Raleigh (1957)
reported a cumulative relapse rate of 14% at one
year and 21% at three years following quiescence
after six to eight months of chemotherapy. His
figures include both bacteriological and radio-
graphic relapses. Ross et al. (1958) reported a
relapse rate of 7% in a two to three year period of
follow-up. Low (1959) reported a relapse rate of
6% in a 2-year follow-up of patients who had six or
more months of multiple drug therapy which
included isoniazid.
The findings for the main subdivisions of the
126 patients are readily summarized. Six (10 %) of
the 61 patients who had had only one year of chemo-
therapy relapsed bacteriologically during the second
and third years, as compared with three (5%) of
65 who had had two or three years of chemotherapy.
In the second and third years, three (5%) of the
57 patients who had been treated at home in the
f rst y ar relapsed as compared with six (9%) of
69 who had been treated in sanatorium. Four (10 %)
f 42 patients with residual cavitation at one year,
the “ open negative ”syndrome, relapsed in the
second or third year, as compared with five (6%)
of 84 without residual cavitation at one year. It may
be concluded that it made comparatively little
difference to the progress of the patients whether
they were treated for one year or for two or more
years, whether they had been originally treated at
home or in sanatorium, and whether they had had
the “ open negative ”syndrome or no cavitation
at the end of the first year.The e was some evidence
that a second year of isoniazid may have prevented
relapse in patients with non-cavitated lesions at one
ye r, for none of 42 patients who received isoniazid
relapse , as compared with five of 42 who received
the placebo-a statistically significant difference.
However, only one of 19 patients with cavitated
l ions, who received the placebo, had a bacterio-
logical elapse (as compared with three of 23 who
rece ved isoniazid) so that the finding of five relapses
in 42 patients may not be representative of the true
relapse rate in non-cavitated lesions. Further data
on the role of isoniazid in the prevention of relapse
during the second year will shortly be available in
another series (see Tuberculosis Chemotherapy
C ntre, 1960) of patients whose disease had attained
bacteriological quiescence at the end of a year of
chemotherapy at home. These additional results
should clarify the position further.
The comparison in the third year of patients who
received either two or three years of chemotherapy,
bas d on the random allocation of 60 patients, is of
intere t. No patient in either series had a bacterio-
logical relapse. Even though the comparison is
based on small numbers, this observation underlines
the importance of control groups in interpreting
the findings of long-term chemotherapy studies.
In the absence of a control group it would have been
tempting but erroneous to conclude that the excellent
results in the group who received chemotherapy for
the third year were due to this continuation of
chemotherapy.
In evaluating these findings it must be borne in
mind that all the patients had originally attended
routine chest clinics on their own initiative because
of symptoms and that the great majority were cli-
nically ill and had far advanced bilateral cavitated
disease. The good results were obtained even though
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the patients were drawn from a poverty-stricken,
malnourished, overcrowded community in the tro-
pics and despite the fact that the patients treated at
home had comparatively little rest, even in the early
stages of treatment. The findings have particular
reliability in view of the high intensity of bacterio-
logical investigation of the patients. Thus, the
patients had, on the average, 13.3 cultures examined
in the second year and 8.7 in the third year, so that
the assessment of bacteriological quiescence is based
on much more extensive bacteriological data than
are usually available in relapse studies.
Considerable evidence is accumulating that it is
difficult to persuade tuberculous patients to co-oper-
ate in the long-term self-administration of drugs,
whatever the nature of those drugs. This has been
shown principally with combinations containing PAS
(Wynn-Williams & Arris, 1958; Luntz & Austin,
1960) and some workers attribute the difficulty speci-
fically to that drug (Poole & Stradling, 1960).
Evidence has, however, been reported that smaller
tablets containing isoniazid alone are no more accept-
able for self-administration than a similar number of
large PAS-containing cachets (Tuberculosis Chemo-
therapy Centre, 1960). It has also been shown in a
study in this Centre that irregularities also occur with
a single daily tablet of isoniazid alone, and even with
a daily placebo (Velu et al., 1960b); the present study
has confirmed these findings. Irregularities, and in
some patients serious omissions of medicaments,
thus represent a major problem of long-term chemo-
therapy in tuberculosis.
There is much controversy concerning the place of
surgery in the treatment of the “ open negative ”
syndrome, that is, bacteriologically quiescent disease
with residual cavitation (Raleigh, 1957; Bloch et al.,
1958; Corpe & Blalock, 1958; Mitchell & Auerbach,
1959). In the present series, patients with the “ open
negative ” syndrome at the end of one year of chemo-
therapy fared slightly less well than patients without
cavitation at that time, but further chemotherapy
with isoniazid alone did not influence the relapse rate.
The patients with residual cavitation who relapsed
responded to further courses of chemotherapy and
their end results may well prove to be as satisfactory
in the long-term follow-up as the results in patients
without residual cavitation.Many developing
countries do not have the resources to treat the
“ open negative ” syndrome surgically, but even for
the technically advanced countries the question
arises whether surgery is justified, especially in view
of the operative mortality and post-operative com-
pl ations (Mitchell & Auerbach, 1959). There is
cl arly an urgent need for more information on the
management of the “ open negative ” syndrome
(Ross et al., 1958; American Trudeau Society, 1959).
Further findings will be reported later from this and
o her studies in this Centre.
Finally, it is of interest to consider the factors
which may be used to assess the progress of patients
with bacteriologically quiescent disease. In this com-
munity, it has emerged that the ESR is often elevated
in patients who have had quiescent disease for two
years or even longer. It is therefore an unsatis-
factory measure of progress, a finding in keeping
with that in East African patients (Courdurier &
Brygoo, 1947; McGregor & Deegan, 1954; Hutton
et al., 1956). Considering the radiographic assess-   
ments, most patients showed no radiographic
improvement in the second or third year. Indeed,
the majority of the patients showed no change in the
second six months of the first year either (Tubercu-
losis Chemotherapy Centre, 1959). Thus, even with
advanced lesions, the maximum radiographic im-
provement usually occurs early and the lesions then
become stabilized. Further radiography confirms
the stability of the lesions but does not usually
demonstrate continuing radiographic improvement,
although calcification may become apparent at a
later stage (Fox, Sutherland & Daniels, 1954; Fox
& Sutherland, 1956, 1959).
In the present study, an independent assessor often
recorded a radiographic improvement or deteriora-
tion because there was a change in the size of residual
cavitation. The majority of such changes, however,
occurred in patients who had a persistently negative
sputum, the assessor being unaware of this fact. It is
open to question how much importance should be
attached to fluctuations in the size of cavities in   
patients who have a persistently negative sputum.   
The changes are almost certainly mechanical in ori-
gin and it is very unlikely in the present study that
they represented activity of the tuberculous disease,
for they did not usually presage relapse. These find-
ings are in keeping with the recommendations of the
American Trudeau Society (1959) that unfavourable
radiographic changes with negative bacteriological
findi gs should not be regarded as a relapse.
Although in the present study, in agreement with
Raleig ’s (1957) findings, an isolated positive culture
in patients undergoing frequent examinations seems
of li tle importance, the occurrence of two or more
positive cultures in a patient with previously qui-
escent disease bacteriologically, was, in the majority
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of cases, followed by a radiographic spread so that
the instability of the lesions in patients in whom
tubercle bacilli reappear in two or more specimens
cannot be doubted.It is clear that the bacteriological
assessments are the most valuable method of follow-
ing the patient’s progress.
It seems reasonable to conclude from the evidence
presented in this report that, in general, at the present
time, the developing countries with their limited
resources need not aim at administering courses of
effective chemotherapy of more than a year’s dura-
tion. This conclusion is strengthened because it was
possible, in the present study, to treat successfully
those patients whose disease relapsed. Thus, at the
end of three years, seven of the nine patients who had
had a relapse had bacteriologically quiescent disease
again (that is, six or more consecutive months of
culture negativity) and in one more the disease was
approaching quiescence (five consecutive months of
culture negativity). The only patient who had active
disease and a positive sputum at three years had
refused to co-operate in further chemotherapy and so
cannot be regarded as a failure of chemotherapy.
There is no evidence in this study that a year of
combined chemotherapy, followed by careful super-
vision, and further chemotherapy if relapse occurred,
gave results in any way inferior to those which might
have been obtained by uninterrupted chemotherapy
for the whole 3-year period.
This study of the progress in the second and third
years of patients with bacteriologically quiescent
disease at one year firmly consolidates the conclu-
sions reached at the end of one year’s treatment that
“ the results of domiciliary chemotherapy as carried
out in this study approach sufficiently closely the
results of sanatorium treatment to suggest that it is
appropriate to treat the majority of patients at home”
(Tuberculosis Chemotherapy Centre, 1959). It has
also been shown (Andrews et al., 1960; Ramakrish-
nan et al., 1961 a1) that there is no special risk to
family contacts in a 2-year period if the patients are
treated at home with isoniazid plus PAS.Considered
together, these studies have established the value of
properly planned domiciliary chemotherapy, even in
most adverse environmental, economic and dietary
circumstances.
The observation of both the patients and the
contacts is continuing and there is every prospect
at a successful 5-year follow-up will be obtained;
further findings for both will be reported later. The
long-term findings for patients and contacts in other
domiciliary studies from this Centre will also be
reported in due course.
XI. SUMMARY
1. In the main analysis of a year’s study of
combined chemotherapy with isoniazid plus PAS
at home or in sanatorium, it was reported that
130 of 163 South Indian patients with pulmonary
tuberculosis had attained bacteriological quiescence
at one year (Tuberculosis Chemotherapy Centre,
1959). Of these, 126 were allocated at random to
treatment at home for a second year with isoniazid
alone or with a placebo, calcium gluconate. The
daily dosage of isoniazid was 200 mg for patients
weighing 100 lb. or more, 175 mg for patients
weighing 80-99 lb. and 150 mg for patients weighing
less than 80 lb. The daily dosage of calcium
gluconate was 500 mg.
2. At two years, 60 of the 61 patients in the
isoniazid series who still had bacteriologically
quiescent disease were allocated at random for a
third year to isoniazid in the same dosage (30
patients) or to the placebo (30 patients).
3. The patients in the calcium series continued
on calcium gluconate in the third year unless their
disease was no longer bacteriologically quiescent
at two years.
4. The main comparisons for the second and third
y ars are between (a) 61 calcium and 65 isoniazid
patients; (b) 57 home and 69 sanatorium patients;
(c) 42 patients with residual cavitation at one year
and 84 patients without cavitation at one year. A
comparison for the third year is made between
30 patients who received two years of chemotherapy
and 30 who received it for three years.
5. One patient (home, cavitated) who received
isoniazid in the second year died in the seventeenth
month, the cause of death being unestablished.
6. At the end of the third year there was relatively
little difference between the progress of patients in
the various subgroups; six (10%) of 61 patients who
1 See article on page 129 of this issue.
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received one year of chemotherapy relapsed bacte-
riologically, as compared with three (5 %) of 65 who
received two or three years of chemotherapy; three
(5%) of 57 patients treated at home in the first year
relapsed as compared with six (9 %) of 69 treated in
sanatorium; four (10%) of 42 patients with the
“ open negative ” syndrome at one year relapsed, as
compared with five (6%) of 84 in the non-cavitated
series. In all, nine (7.1%) of the 126 patients relapsed
in the second or third year, eight (6.3%) of these
having relapsed in the second year.
7. None of the 60 patients in the comparison of
two years and three years of chemotherapy, based
on random allocation, relapsed (although one in the
3-year series produced an isolated positive culture at
36 months).
8. The regularity of self-administration of medi-
cine was checked by counting the stocks of pills
and by urine tests for isoniazid. Pill counting at
surprise visits to the home revealed inaccuracies of
the order of 20%, there being no major differences
between the patients originally treated at home and
in sanatorium or between the males and the females.
Urine specimens were obtained at planned visits to
the Centre for the patients receiving isoniazid. They
yielded negative results in approximately 20 % of tests.
9. In addition, the progress in the second and
third years of the 10 patients with disease whose
bac e iological status at one year was in doubt has
been studied. Of these 10 patients, three had a
b cter ological relapse; in each instance an appar-
ently isolated positive culture at 12 months proved
to be the beginning of the relapse.
10. It is concluded that in the second and third
ye rs there was relatively little difference between
the patients whose disease attained quiescence
following a year of domiciliary chemotherapy and
th se whose disease attained quiescence following a
ear’  treatment with the same combination of
drugs in sanatorium. Secondly, there was no
evidence that a second or third year of treatment
with isoniazid alone gave better results than a year
of chemotherapy followed by careful observation of
the patient and further chemotherapy if a relapse
occurred. Thirdly, patients with residual cavitation
at one year had slightly higher relapse rates than
those without residual cavitation.
11. Taken in conjunction with earlier studies, the
present study confirms the value of properly planned
domiciliary chemotherapy for one year even in the
most adverse environmental and dietary circum-
stances.
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RÉSUMÉ
Poursuivant la comparaison des résultats à brève et
longue échéance du traitement chimiothérapique de la
tuberculose à domicile et en sanatorium parmi la popula-
tion pauvre et mal nourrie de certains quartiers de Ma-
dras, les auteurs de cet article ont suivi 130 malades chez
lesquels la maladie avait atteint un stade de quiescence
a la fin de la première année de traitement par l’isoniazide
et le PAS.
Dès la fin de cette première année, les malades suivis
continuèrent tous leur traitement – réel ou fictif – à
domicile. Durant la deuxième année, c’est-à-dire celle
qui a suivi le traitement combiné, la moitié environ de ces
patients a continué à être soumis au traitement à l’iso-
niazide, mais sans adjonction de PAS. L’autre moitié,
servant de témoins, recevait un placebo, en l’occurrence
du gluconate de calcium. Sur 126 malades, répartis
arbitrairement en groupes de traitement, 8 eurent des
rechutes au cours de la deuxième année et un au tours de
la troisième année, ce qui porte à 9 cas, soit 6,3%, la
proportion des rechutes, chiffre qui supporte avanta-
geusement la comparaison avec ceux qu’ont trouves
d’autres auteurs dans d’autres series. Durant la troi-
ième année, 50% des patients qui avaient reçu l’isonia-
zide seul poursuivirent ce traitement, l’autre moitié rejoi-
gnant le groupe recevant le gluconate.
Les résultats montrèrent que durant la deuxième et la
t oisième année, il n’y avait que peu de différence entre
les suj ts qui, au cours de la première année, avaient été
traités a domicile d’une part, en sanatorium d’autre part.
Une deuxième ou une troisième année de traitement,
par l’isoniazide seul, n’a pas amélioré les résultats
obtenus la première année par le traitement combiné.
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éant bien entendu que les patients ont été attentivement
surveillés et les rechutes traitées dès leur apparition.
L’état général des malades présentant des lesions
cavitaires résiduelles à la fin de la premiere année était
peut-être un peu moins bon que celui des malades exempts
de ces lésions, sans pour autant que la proportion des
rechutes dans l’un et l’autre groupe accuse des différences
significatives.
D’une façon générale, on peut conclure que les pays
en voie de développement, dont les ressources sont res-
treintes, peuvent envisager de limiter à une année le
traitement chimiothérapique des tuberculeux. Cela
impl que évidemment que les rechutes soient dépistées
et immédiatement traitées. Dans la présente étude, 7 des
9 cas de rechutes avaient retrouvé leur état quiescent à
la fin de la troisième année. Il faut relever d’autre part
la diffi ulté d’obtenir des malades qu’ils prennent régu-
lièrement leur médicament. Cette irrégularité est un
écueil dans l’organisation d’un traitement à long terme à
d micil .
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